08.02.2010TIME: 17:35:00
LAST
14,86 €
OPEN
14,75 €
CHANGE
+0,75%»
COMPANY PIPELINE NEWS INVESTOR RELATIONS   Search
 
mission statement


 
COMPANY COMPANY
  ThromboGenics is a leading biopharmaceutical company focused on the discovery and development of novel therapeutics for diseases related to... more »  
 
English
Nederlands
English
Nederlands
COMPANY
PIPELINE PIPELINE
  ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more »  
  foto2 Pipeline overview
NEWS & EVENTS NEWS & EVENTS
 

December 16, 2009

ThromboGenics completes patient enrolment of second Phase III Trial of Microplasmin... more »

ThromboGenics rondt de rekrutering van patiënten af in tweede Fase III studie met microplasmine... meer »

December 11, 2009

ThromboGenics announces start of Phase II trial of Microplasmin... more »

ThromboGenics kondigt start aan van Fase II studie met Microplasmine... meer »

 
  All rights reserved © ThromboGenics 2006 Last update: January 4, 2010 Inspired by Echo
 
PIPELINE COMPANY Pipeline overview